Trial Profile
A Randomized, Double Blind, Parallel Group, Placebo-controlled Trial to Study the Efficacy and Safety of Two Oral Doses of Prurisol Administered Twice Daily for Twelve Weeks to Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Abacavir (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Innovation Pharmaceuticals
- 15 Mar 2018 According to an Innovation Pharmaceuticals media release, topline data from this trial is expected in Q2 2018.
- 21 Dec 2017 According to an Innovation Pharmaceuticals media release, topline data from this trial are expected to be released in the first quarter of 2018.
- 21 Dec 2017 According to an Innovation Pharmaceuticals media release, status changed from active, no longer recruiting to completed.